Bravatek Solutions Inc (BVTK)

[stemcell]

march 2016 ecrypt one BS PR: don't get too warm and fuzzy over google pr lol...tom's been regurgitating ecrypt one for years and years....to this date not a single entity confirmed as ever using it! google's digital accelerator program available to any biz on earth lol if you spend $10k in a quarter they give you a dedicated account specialist to assist with marketing

Bravatek Negotiating Cross-Licensing Deal With BiObex(R) for Ecrypt One, Major Contract for Telecom Services GroupPress Release | 03/30/2016
Bravatek Negotiating Cross-Licensing Deal With BiObex(R) for Ecrypt One, Major Contract for Telecom Services Group
Bravatek Solutions, Inc. Is in the Final Stages of Negotiating an OEM Deal for Ecrypt One With Two-Factor Authentication Innovator BiObex While Negotiating Viking Telecom Work With Another Major Wireless Services Provider

AUSTIN, TX--(Marketwired - March 30, 2016) - Bravatek Solutions, Inc. (OTC PINK: BVTK) is pleased to announce that the company is in final negotiations for an OEM (Original Equipment Manufacturer) deal for its Ecrypt One Cybersecurity email product with BiObex, the developer of a high-caliber two-factor authentication solution called SAFE ("Strong Authentication Front End").

The terms being negotiated include a cross-licensing agreement, integrating BiObex's SAFE Technology as the Public Key Infrastructure (PKI) within the Ecrypt One Cybersecurity email system, providing both Bravatek and BiObex with a white label secure email and strong authentication solution targeted mainly at government and military procurement opportunities.

As reported by Market Research Media, the U.S. government sector is under constant pressure to boost investments in cyber security technologies. As a result annual cyber security spending of the US Federal government is bigger than any national cyber security market, including both public and private sector. The U.S. Federal cybersecurity market size is estimated to grow to $22 Billion by 2022, at a steady CAGR of 4.4%.

"We recently announced that we were aggressively pursuing licensing and other opportunities for Ecrypt One as part of our strategy to get the product faster to the end customer," commented Dr. Thomas A. Cellucci, Bravatek's Chairman and CEO. "BiObex is a licensee we are excited to work with. There is synergy between our two technologies, and they have extensive government and military contacts looking for just this kind of solution."

YAWN....